Brought to you by 
Telcare gets $25.4mm in first close of Series B
27 Apr 2021
Executive Summary
Glucose monitoring device developer Telcare Inc. has raised $25.4mm in the first close of its Series B financing led by new investor Sequoia Capital with participation from returning shareholder Qualcomm (through its Qualcomm Life Fund) and undisclosed investors. According to the Form D, the company could bring in another $13.1mm in the round.
Deal Industry
- Medical Devices
-
Medical Devices
- Diagnostic Equipment & Supplies
-
In Vitro Diagnostics
- Glucose Testing
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Telcare gets $25.4mm in first close of Series B
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice